维普中文期刊产品整合服务
99篇 您的检索式:作者名="STATHOPOULOS GP"
    题名 作者 年代 出处 被引量
1Comparison of cisplatin-paclitaxel combination versus cisplatin-etoposide in pa- tients with small-cell lung cancer: A Phase Ⅲ study 显示文摘Dimitroulis J Rapti A Stathopoulos GP 2008Oncol Rep2008,20,4:1
2Phase U trial of bi- weekly administration of vinorelbine and gemcitabine in pre-treated advanced breast cancer显示文摘Stathopoulos GP Rigatos SK Pergantas N 2002J Clin Oncol2002,20,1:1
3Front-line paversus paclitaxel-carboplatin in patients with advanced non-small--cell lung cancer: a randomized phase Ⅲ trial显示文摘Stathopoulos GP Veslemes M Georgatou N 2004Ann Oncol2004,15,7:1
4Front-line paclitaxel and topotecan chemotherapy in advanced or metastatic non-small-cell lung cancer: a phase Ⅱ trial 显示文摘Stathopoulos GP Katis C Tsavdaridis D 2006Cancer Chemother Pharmacol2006,58,4:1
5Liposomal oxali- platin in the treatment of advanced cancer: A phase 1 study显示文摘Stathopoulos GP Boulikas T Kourvetaris A 2006Anticancer Res2006,26,2:1
6Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer 显示文摘Antoniou D Pavlakou G Stathopoulos GP 2006Lung Cancer2006,53,2:1
7Epidemiology and Pathogenesis of esophageal cancer: management and its controversial results 显示文摘StathoPoulos GP Tsiaras N 2003Oncolep2003,10,:1
8Comparison of cisplatin-pa clitaxel combination versus cisplatin-etoposide in patients with small-cell lung cancer:a PhaseⅢstudy显示文摘Dimitroulis J Rapti A Stathopoulos GP 2008Oncol Rep2008,20,4:1
9Paclitaxel and carboplatin in pretreated advanced gastric cancer: a phase Ⅱ study 显示文摘Stathopoulos GP Rigatos SK Fountzilas G 2002Oncol Rep2002,9,1:1
10An- giogenic interactions of vascular endothelial growth factor, of thymidine phosphorylase, and of p53 protein expression in locally advanced gastric cancer显示文摘Giatromanolaki A Koukourakis MI Stathopoulos GP 2000Oncol Res2000,12,1:1
11Weekly administration of topotecan-paclitaxel as second-line treatment in ovarian cancer显示文摘Stathopoulos GP Malamos NA Aravantinos G 2007Cancer Chemother Pharmacol2007,60,1:1
12A muhicenter phase Ⅲ trial comparing irinotecan-gemcitabinc (IG) with gemcitabine (G) monotherapy as first-line treatment in patients with locally advanced or metastatic pancreatic cancer 显示文摘Stathopoulos GP Syrigos K Aravantinos G 2006Br J Cancer2006,95,5:1
13Predictive val- ue of D-dimer plasma levels in response and progressive disease in patients with lung cancer 显示文摘Antoniou D Pavlakou G Stathopoulos GP 2006Lung Cancer2006,53,2:1
14TopoisomeraseII alpha expression in squamous cell carcinomas of the head and neck显示文摘Stathopoulos GP Kapranos N Manolopoulos L 2000Anticancer Res2000,20,1:1
15Front-line treatment of inoperable or metastatic pancreatic cancer with gemcitabine and capecitabine: an intergroup, multicenter, phase Ⅱ study显示文摘Stathopoulos GP Syrigos K Polyzos A 2004Ann Oncol2004,15,2:1
16Phase Ⅱ trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer 显示文摘Stathopoulos GP Rigotos SK Pergantas N 2002J Clin Oncol2002,20,:1
17Paclitaxel combine with cisplatin as Second-line treatment in patients with advanced nonsmall cell lung cancers refractory to cisplatin 显示文摘 Rigatos Malamos NA 1999Oncol Rep1999,6,4:1
18Predictive value of D-dimer plasma levels in response and progressive disease in patients with lung cancer显示文摘Antoniou D Pavlakou G Stathopoulos GP 2006Lung Cancer2006,53,2:1
19Systemic lipoplatin infusion results in preferential tumor uptake in human studies 显示文摘BOULIKAS T STATHOPOULOS GP VOLAKAKIS N 2005Anticancer Res2005,25,4:1
20Liposomal oxallplatln in the treatment of advanced cancer: a phase Ⅰ study 显示文摘STATHOPOULOS GP BOULIKAS T KOURVETARIS A 2006Anticancer Res2006,26,2:1
返回顶部 每页显示:
共5页 首页 上一页 第1页 下一页 末页 /5 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费